Evaluating effectiveness of syringe exchange programmes: current issues and future prospects.

Although a large body of international literature has found syringe exchange programmes (SEPs) to be associated with reduced incidence of blood borne pathogens among injection drug users, recent studies have fuelled controversy surrounding SEP effectiveness. Existing studies are observational in nature and have seldom considered ecologic aspects affecting SEP functioning and evaluation. The authors apply concepts from infectious disease epidemiology to discuss the direct and indirect effects of SEP upon the spread of blood borne pathogens in drug users, their social networks and the broader community. Further, the authors discuss social policies, particularly drug control policies, which have directly and/or indirectly limited SEP functioning at local and national levels. A critical review of the literature suggests that biases common to observational studies can account for higher HIV incidence among SEP attenders relative to non-attenders. Strong selection factors often lead high-risk drug users to be over-represented among SEP attenders. Failure to account for these factors and the indirect effects of SEPs can bias interpretations of programme effectiveness. Future SEP evaluations should consider behavioural data, the local ethnographic context, the prevalence of infectious disease in the groups under study and the structural components of SEP that are most and least effective at reducing incidence of blood borne pathogens. Hierarchical models that take into account the ecological dimensions of SEP are recommended as an approach for future studies. Beyond methodologic concerns, the authors discuss social, legal and programmatic obstacles that must be overcome in order to maximise SEP effectiveness.

[1]  C Latkin,et al.  People and places: behavioral settings and personal network characteristics as correlates of needle sharing. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[2]  A. Diez-Roux,et al.  Bringing context back into epidemiology: variables and fallacies in multilevel analysis. , 1998, American journal of public health.

[3]  M E Halloran,et al.  Study designs for dependent happenings. , 1991, Epidemiology.

[4]  E. Franco,et al.  High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. , 1997, American journal of epidemiology.

[5]  Julio S. G. Montaner,et al.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.

[6]  R. Curtis,et al.  The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. , 1994, Social science & medicine.

[7]  C. Hankins,et al.  Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal? , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[8]  J. Parry,et al.  The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales , 1998, Epidemiology and Infection.

[9]  F. Bastos,et al.  Cities Responding to HIV-1 Epidemics among Injecting Drug Users , 1998 .

[10]  M. Schechter,et al.  Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[11]  M. Alary,et al.  Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study". , 1998, American journal of epidemiology.

[12]  T. Rhodes,et al.  Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. , 1999, AIDS.

[13]  E. Franco,et al.  DRS. BRUNEAU, LAMOTHE, AND FRANCO REPLY , 1998 .

[14]  R Brookmeyer,et al.  Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. , 1995, American journal of epidemiology.

[15]  D. Vlahov,et al.  Syringe exchange not associated with social network formation: results from Baltimore , 2000, AIDS.

[16]  M E Halloran,et al.  Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.

[17]  D. D. Des Jarlais,et al.  Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. , 1998, Public health reports.

[18]  R A Coutinho,et al.  Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. , 1994, American journal of public health.

[19]  Martina Morris,et al.  Epidemiology and Social Networks: , 1993 .

[20]  Y. Cheung,et al.  Harm Reduction: A New Direction for Drug Policies and Programs , 1998 .

[21]  A. Ball Overview: Policies and Interventions to Stem HIV-1 Epidemics associated with Injecting Drug Use , 1998 .

[22]  E H Kaplan,et al.  A method for evaluating needle exchange programmes. , 1994, Statistics in medicine.

[23]  G A Satten,et al.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.

[24]  J. Grund,et al.  Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. , 1992, British journal of addiction.

[25]  M. Martínez de Pancorbo,et al.  The validation of statements by IDUs based on the analysis of blood traces on their used syringes. , 1998, AIDS care.

[26]  R. Heimer,et al.  Syringe use and reuse: effects of syringe exchange programs in four cities. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[27]  M. Alter,et al.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. , 1995, American journal of public health.

[28]  N. Weiss,et al.  Syringe exchange and risk of infection with hepatitis B and C viruses. , 1999, American journal of epidemiology.

[29]  S. Huttly,et al.  The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. , 1997, International journal of epidemiology.

[30]  B Junge,et al.  Satellite exchange in the Baltimore Needle Exchange Program. , 1998, Public health reports.

[31]  M. Boily,et al.  Mathematical Models of Disease Transmission: A Precious Tool for the Study of Sexually Transmitted Diseases , 1997, Canadian journal of public health = Revue canadienne de sante publique.

[32]  D. D. Des Jarlais,et al.  Maintaining low HIV seroprevalence in populations of injecting drug users. , 1995, JAMA.

[33]  T. S. Jones,et al.  Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[34]  E. V. van Ameijden,et al.  Maximum impact of HIV prevention measures targeted at injecting drug users , 1998, AIDS.

[35]  S. Friedman,et al.  Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health? , 1999, Addiction.

[36]  E H Kaplan,et al.  HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. , 1994, Journal of acquired immune deficiency syndromes.

[37]  M. Halloran,et al.  Causal Inference in Infectious Diseases , 1995, Epidemiology.

[38]  R. Rothenberg,et al.  Sociometric risk networks and risk for HIV infection. , 1997, American journal of public health.

[39]  D. Vlahov,et al.  Can HIV epidemics among injection drug users be prevented? , 1998, AIDS.

[40]  M. Busch,et al.  Use of a new 'less-sensitive enzyme immunoassay' testing strategy to identify recently infected persons in a Brazilian prison: estimation of incidence and epidemiological tracing. , 1999, AIDS.

[41]  D. Vlahov,et al.  Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[42]  J. Rich,et al.  Detection of HIV‐1 nucleic acid and HIV‐1 antibodies in needles and syringes used for non‐intravenous injection , 1998, AIDS.

[43]  Samuel R Friedman,et al.  HIV incidence among injecting drug users in New York City syringe-exchange programmes , 1996, The Lancet.

[44]  R Brookmeyer,et al.  Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[45]  K. Dolan,et al.  AIDS behind bars: preventing HIV spread among incarcerated drug injectors. , 1995, AIDS.

[46]  P. Lurie,et al.  A Tale of Two Countries: Attempts to Control HIV among Injecting Drug Users in Australia and the United States , 1997 .

[47]  M. Schechter,et al.  Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. , 1999, AIDS.

[48]  L. Metsch,et al.  HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. , 2000, Drug and alcohol dependence.

[49]  S. Aral Heterosexual transmission of HIV: the role of other sexually transmitted infections and behavior in its epidemiology prevention and control. , 1993, Annual review of public health.

[50]  J. Rich,et al.  Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[51]  A. Moss,et al.  Invited commentary: needle exchange--no help for hepatitis? , 1999, American journal of epidemiology.

[52]  G. Y. Wong,et al.  Contextually Specific Effects and other Generalizations of the Hierarchical Linear Model for Comparative Analysis , 1991 .

[53]  G. Stimson,et al.  Drug injecting and HIV infection : global dimensions and local responses , 1998 .

[54]  E H Kaplan,et al.  Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users. , 1992, The Journal of infectious diseases.

[55]  M. Morris,et al.  Sexual networks and HIV. , 1997, AIDS.

[56]  C. Archibald,et al.  A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. , 1998, AIDS care.

[57]  T. S. Jones,et al.  A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[58]  J. Kaldor,et al.  Effectiveness of needle-exchange programmes for prevention of HIV infection , 1997, The Lancet.

[59]  Sandra D. Lane,et al.  The Public Health Impact of Needle Exchange Programs in the United States and Abroad , 1993 .

[60]  E Massad,et al.  HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[61]  P Lurie,et al.  Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. , 1998, AIDS.

[62]  Peter Lurie Invited commentary: le mystère de Montréal. , 1997, American journal of epidemiology.

[63]  S. Strathdee,et al.  Drug Use and the Spread of HIV/AIDS in South America and the Caribbean , 1999 .

[64]  G. Stimson,et al.  Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales. , 1993, Addiction.

[65]  G. Stimson AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. , 1995, Social science & medicine.

[66]  K. Vranizan,et al.  Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[67]  Patricia G. Erickson,et al.  18 Two Steps Forward, One Step Back: Anti-User Bias in New York State's Approach to Needle Exchange , 1997 .

[68]  P. Lurie,et al.  An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA , 1997, The Lancet.

[69]  R. Brookmeyer,et al.  Measuring HIV-1 incidence in northern Thailand: prospective cohort results and estimates based on early diagnostic tests. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[70]  R. Heimer,et al.  Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens. , 1996, The Journal of infectious diseases.

[71]  R. Booth,et al.  The prevalence of additional injection-related HIV risk behaviors among injection drug users. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[72]  M. Kretzschmar,et al.  Modelling the spread of HIV in social networks of injecting drug users , 1998, AIDS.

[73]  J. Wrench,et al.  Outbreak of HIV infection in a Scottish prison , 1995, BMJ.

[74]  D. Hartel,et al.  Needle exchange use among a cohort of injecting drug users , 1996, AIDS.

[75]  D. Jolley,et al.  Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm‐reduction programme , 1995, AIDS.

[76]  Arthur L. Reingold,et al.  Public Health Impact of Needle Exchange Programs in the United States and Abroad: Summary, Conclusions, and Recommendations, The , 1993 .

[77]  P. Telles Preventing HIV/AIDS and other sexually transmitted diseases among injecting drug users in Rio de Janeiro , 1999 .

[78]  E. Franco,et al.  Assessing Harm Reduction Strategies: The Dilemma of Observational Studies , 1997 .

[79]  Thomas W. Valente Network models of the diffusion of innovations , 1996, Comput. Math. Organ. Theory.

[80]  R. Brookmeyer,et al.  The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. , 1995, American journal of epidemiology.

[81]  P. Lurie DR. LURIE REPLIES , 1998 .

[82]  M Susser,et al.  The logic in ecological: I. The logic of analysis. , 1994, American journal of public health.

[83]  D. Purchase,et al.  Syringe exchange in the United States, 1996: a national profile. , 1999, American journal of public health.

[84]  J. Nelles,et al.  Preventing HIV transmission in prison: a tale of medical disobedience and Swiss pragmatism , 1995, The Lancet.

[85]  R. Anderson,et al.  Human Immunodeficiency Virus Transmission and the Role of Other Sexually Transmitted Diseases: Measures of Association and Study Design , 1996, Sexually transmitted diseases.

[86]  R A Coutinho,et al.  Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. , 1989, American journal of public health.